Not exact matches
The trial conducted at the WRAIR Clinical Trial Center in Silver Spring, Md., is assessing the impact of pre-existing
flavivirus immunity in volunteers who had been vaccinated
against yellow fever or Japanese encephalitis — both viral cousins to Zika — prior to receiving ZPIV.
The researchers say the culture model will greatly increase knowledge about how
flaviviruses infect ticks and could become a tool to evaluate medical countermeasures
against tick - borne viruses.
A new research study from University of North Carolina researchers shows that individuals who have been previously infected with a
flavivirus — specifically dengue and Zika viruses — could have antibodies that protect
against Zika.
Given the concerns for immune enhancement with other similar
flaviviruses, like yellow fever and Japanese encephalitis, ZPIV will be tested in some volunteers who will first be vaccinated
against one of these other
flaviviruses.